Becton, Dickinson and Company (BDX)
Quantitative Summary
DeterministicAt 25.7x earnings — a 61% discount to the sector average of 65.2x — BDX is in the lower valuation range. Strong operational fundamentals (Piotroski 7/9) with Altman Z of 2.1. DCF fair value of $330 implies 112% upside from current prices based on model assumptions.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe fundamental economics of Becton, Dickinson and Company reveal a capital allocation challenge despite respectable revenue expansion. The return on invested capital stands at 4.2%, which falls significantly below the weighted average cost of capital of 6.2%, resulting in a negative spread that erodes shareholder value over time. This dynamic is further illuminated by the DuPont decomposition, where an equity multiplier of 2.18x suggests leverage is propping up a return on equity of 6.6% rather than operational efficiency; notably, asset turnover remains low at 0.39x while net margins sit comfortably at 7.7%. While the Piotroski F-Score of 7/9 indicates strong financial stability and the Beneish M-Score of -2.63 signals minimal earnings manipulation risk, the Altman Z-Score of 2.2 places the firm in a zone requiring close monitoring for potential distress given its capital structure constraints.
Valuation metrics present a complex divergence between market pricing and intrinsic value models. The current P/E ratio of 25.2x trades at a discount to the sector average of 30.8x, yet this compression appears misaligned with discounted cash flow analysis which implies a fair value of $436, suggesting substantial upside potential based on long-term free cash flow assumptions. However, these optimistic valuations rely heavily on an implied ten-year free cash flow growth rate of merely 1.3%, indicating the market may be pricing in stagnation rather than expansion. This disconnect is reinforced by factor data showing a negative Fama-French alpha of -18.77% annually and a weak profitability factor score, suggesting that despite its value tilt characteristics, the stock has underperformed relative to risk-adjusted benchmarks over recent periods.
Recent insider activity adds another layer of caution to the investment thesis, with $548,637 in net selling observed over the last 90 days. This outflow from management coincides with the negative ROIC-WACC spread and weak profitability factor, raising questions about confidence in near-term margin expansion or capital deployment strategies. While the low Altman Z-Score and high Piotroski score provide a buffer against immediate insolvency risks, the combination of value-destructive returns on invested capital, insider distribution, and underperformance across key risk factors suggests that current valuation premiums may not be fully supported by underlying operational trends without significant future margin improvement or asset base optimization.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
Interactive5-year two-stage DCF. Terminal growth 3%. Default sliders match the pre-computed base case. Drag to explore scenarios. Not investment advice.
The growth rate the market implicitly expects over the next 10 years to justify today's price. Compare with historical growth of 8% YoY revenue.
Sensitivity Matrix
| TG ↓ / WACC → | 6% | 7% | 9% |
|---|---|---|---|
| 2% | $347 | $263 | $171 |
| 3% | $465 | $330 | $200 |
| 4% | $700 | $442 | $242 |
Center = base case. Green = >10% upside, Red = >10% downside vs $144.43.
Pre-computed DCF: WACC=7.0%, terminal growth 3%. Fair value $330 (+112.4%). Not investment advice.
Valuation Context
Currently trading 28% below its 5-year average P/E of 34.9x.
Price Chart with Moving Averages
Technical Setup
AI GeneratedBecton, Dickinson and Company currently trades at $143.47 within the healthcare sector, presenting a snapshot where institutional positioning can be inferred through specific technical alignments rather than direct price targets. The absence of explicit Moving Average crossover data or volume metrics in the provided dataset prevents a definitive conclusion regarding whether larger market participants are aggressively accumulating or distributing shares; however, the static nature of the current price relative to broader historical trends often suggests a period of consolidation where major players may be waiting for clearer directional catalysts before committing significant capital. In such environments, institutional behavior frequently shifts from active trading to strategic observation, utilizing the lack of immediate volatility to reassess valuation models without triggering noticeable volume spikes that would signal an imminent breakout or breakdown. The current market structure implies a neutral-to-cautious stance among sophisticated investors who typically avoid entering large positions during ambiguous technical setups lacking confirmed trend momentum. Without evidence of sustained above-average volume supporting price increases, or conversely, heavy selling pressure driving prices below key support levels, the broader financial ecosystem appears to be in a state of equilibrium where supply and demand are relatively balanced at this specific price point. This dynamic often results in sideways movement, allowing institutional managers to refine their entry strategies while avoiding the risks associated with chasing momentum that may not yet have established itself as a reliable trend for long-term capital allocation decisions.
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Insider Activity (Last 90 Days)
Open-market buys vs sells by company insiders. Source: yfinance.
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Dividend History
| Date | Amount | Change |
|---|---|---|
| 2026-03-10 | $1.0500 | +27.2% |
| 2025-12-08 | $0.8255 | +1.0% |
| 2025-09-08 | $0.8176 | 0.0% |
| 2025-06-09 | $0.8176 | 0.0% |
| 2025-03-10 | $0.8176 | 0.0% |
| 2024-12-09 | $0.8176 | +9.5% |
| 2024-09-09 | $0.7469 | 0.0% |
| 2024-06-10 | $0.7469 | 0.0% |
| 2024-03-07 | $0.7469 | 0.0% |
| 2023-12-07 | $0.7469 | +4.4% |
| 2023-09-07 | $0.7154 | 0.0% |
| 2023-06-08 | $0.7154 | 0.0% |
Dividend and split data from SEC filings and market data. Amounts are per share, not adjusted for splits. Source: yfinance.
Risk Profile
Sharpe = risk-adjusted return (higher is better). Max drawdown = largest peak-to-trough decline. 1,200+ trading days.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fama-French 5-Factor Exposure
Academic factor model decomposition — what's really driving this stock's returns.
Fama-French 5-Factor Model. Data: Kenneth French Data Library. Regression over 3 years of daily returns.
Fundamentals
Smart Money Flow
Institutional 13F filings from top hedge funds. Positions updated quarterly from SEC EDGAR.
| Fund | Quarter | Shares Change | % Change | Action |
|---|---|---|---|---|
| Citadel Advisors | 2026-Q1 | -30,300 | -32.4% | Decreased |
| Bridgewater Associates | 2026-Q1 | +457 | +5.1% | Increased |
| DE Shaw | 2026-Q1 | -21,271 | -100.0% | Exited |
| Millennium Management | 2026-Q1 | -41,603 | -92.2% | Decreased |
| Point72 Asset Mgmt | 2026-Q1 | -11,000 | -46.4% | Decreased |
| Citadel Advisors | 2025-Q4 | -24,000 | -20.4% | Decreased |
| Millennium Management | 2025-Q4 | -28,476 | -38.7% | Decreased |
| Two Sigma Investments | 2025-Q4 | +35,459 | +3223.6% | Increased |
| DE Shaw | 2025-Q4 | -40,355 | -65.5% | Decreased |
| Bridgewater Associates | 2025-Q4 | -462 | -4.9% | Decreased |
| Point72 Asset Mgmt | 2025-Q4 | +21,900 | +1216.7% | Increased |
Source: SEC 13F-HR filings. 13F data is delayed ~45 days after quarter end. Not investment advice.
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like IHI or XHE, the fund manager is mechanically forced to buy or sell BDX shares regardless of Becton, Dickinson and Company's individual fundamentals. We estimate $7.0B of passive capital is structurally linked to BDX through 8 tracked ETFs. This substantial passive exposure means that ETF inflows and outflows — not company fundamentals — can dominate daily volume on this stock.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in Becton, Dickinson and Company to visualize passive redemption contagion across ETFs and collateral stocks.
If Becton, Dickinson and Company (BDX) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Abbott Laboratories (ABT) as the most exposed collateral stock, sharing 2 ETFs with BDX. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 36 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
BDX Ownership Dynamics
Passive funds hold 1 in every 6 BDX shares, reducing daily market volatility.
Becton, Dickinson and Company (BDX) exerts notable gravity on the passive index market, currently representing 4.6% of the IHI (IHI) and 1.5% of the XHE (XHE). Across 35 tracked ETFs, approximately 46M shares (16.8% of float) are held by passive funds and rarely trade on the open market. This level of passive ownership means index rebalances can create outsized volume events.
ETFs with Highest BDX Exposure
Float lock-up computed from 35 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
BDX Institutional Volume Profile
252-day volume distribution by price level. The Point of Control (POC) marks — the price where the most institutional volume transacted — an implicit support/resistance floor.
The highest-volume price zone for Becton, Dickinson and Company over the past year sits near $148.62 (13% of 252-day volume). The current price of $144.43 sits 2.8% below the POC — suggesting potential mean-reversion upside if institutional demand reasserts at this level. The highly concentrated volume profile (13% at POC) indicates strong consensus on fair value — institutional participants have repeatedly transacted near this price.
Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.
BDX Capital Efficiency
How efficiently does Becton, Dickinson and Company convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
Becton, Dickinson and Company converts 54% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment. However, the ROIC-WACC spread is negative (-2.8%), suggesting reinvested capital is destroying shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-12 | 26 | $143.15 | $3,721.9 |
| 2026-05-11 | 2,445 | $149.43 | $365,356.35 |
| 2026-05-08 | 299,911 | $153.26 | $46.0M |
| 2026-05-06 | 1,505 | $144.17 | $216,975.85 |
| 2026-05-05 | 1,903 | $146.31 | $278,427.93 |
| 2026-05-04 | 88 | $149.31 | $13,139.28 |
| 2026-04-28 | 597 | $150.22 | $89,681.34 |
| 2026-04-20 | 2,914 | $158.54 | $461,985.56 |
| 2026-04-16 | 1,333 | $155.52 | $207,308.16 |
| 2026-04-15 | 2,757 | $155.73 | $429,347.61 |
| 2026-04-14 | 2,694 | $155.43 | $418,728.42 |
| 2026-04-07 | 6,998 | $155.32 | $1.1M |
| 2026-04-02 | 515 | $156.34 | $80,515.1 |
| 2026-04-01 | 2,446 | $157.23 | $384,584.58 |
| 2026-03-27 | 83 | $157.38 | $13,062.54 |
| 2026-03-26 | 197 | $158.27 | $31,179.19 |
| 2026-03-25 | 71 | $155.92 | $11,070.32 |
| 2026-03-24 | 517 | $156.23 | $80,770.91 |
| 2026-03-23 | 2 | $154.13 | $308.26 |
| 2026-03-18 | 44,890 | $161.64 | $7.3M |
| 2026-03-09 | 477 | $167.12 | $79,716.24 |
| 2026-03-06 | 5,722 | $169.94 | $972,396.68 |
| 2026-03-05 | 426 | $171.49 | $73,054.74 |
| 2026-03-02 | 1,155 | $176.48 | $203,834.4 |
| 2026-02-24 | 255 | $184.34 | $47,006.7 |
| 2026-02-23 | 2,039 | $185.39 | $378,010.21 |
| 2026-02-20 | 1,321 | $182.47 | $241,042.87 |
| 2026-02-09 | 14 | $210.02 | $2,940.28 |
| 2026-02-05 | 6,454 | $207.87 | $1.3M |
| 2026-01-22 | 43 | $206.18 | $8,865.74 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Institutional Holdings (13F Filings)
Raw SEC 13F-HR filings from institutional investment managers. Shows exact share counts and portfolio values as reported to the SEC.
| Fund | Quarter | Shares | Value ($K) |
|---|---|---|---|
| Citadel Advisors | 2026-Q1 | 63,100 | $9,921,213K |
| Two Sigma Investments | 2026-Q1 | 36,559 | $5,748,172K |
| Point72 Asset Mgmt | 2026-Q1 | 12,700 | $1,996,821K |
| Bridgewater Associates | 2026-Q1 | 9,496 | $1,493,056K |
| Millennium Management | 2026-Q1 | 3,500 | $550,305K |
| Citadel Advisors | 2025-Q4 | 93,400 | $18,126,138K |
| Millennium Management | 2025-Q4 | 45,103 | $8,753,139K |
| Two Sigma Investments | 2025-Q4 | 36,559 | $7,095,005K |
| Point72 Asset Mgmt | 2025-Q4 | 23,700 | $4,599,459K |
| DE Shaw | 2025-Q4 | 21,271 | $4,128,063K |
| Bridgewater Associates | 2025-Q4 | 9,039 | $1,754,199K |
| Citadel Advisors | 2025-Q3 | 117,400 | $21,973,758K |
| Millennium Management | 2025-Q3 | 73,579 | $13,771,781K |
| DE Shaw | 2025-Q3 | 61,626 | $11,534,538K |
| Bridgewater Associates | 2025-Q3 | 9,501 | $1,778,302K |
Source: SEC 13F-HR filings. Values reported in thousands. 13F data is delayed ~45 days after quarter end.
Price Correlations
Statistical correlation of daily returns with other stocks. High correlations indicate stocks that move together; negative correlations can offer diversification.
| Peer | 252-Day (1Y) | 126-Day (6M) | Direction |
|---|---|---|---|
| WTGXX | NaN | NaN | |
| MTD | 0.483 | 0.389 | Moderate |
| ZBH | 0.472 | 0.460 | Moderate |
| GEHC | 0.468 | 0.402 | Moderate |
| MRK | 0.456 | 0.471 | Moderate |
| MDT | 0.454 | 0.457 | Moderate |
| DHR | 0.453 | 0.393 | Moderate |
| SW | 0.453 | 0.499 | Moderate |
| SWK | 0.450 | 0.453 | Moderate |
| TMO | 0.443 | 0.294 | Moderate |
Pearson correlation of daily log returns. 252d ≈ 1 trading year. Computed from price history. Not investment advice.
Compare BDX to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-02.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.